7-month duration of SARS-CoV-2 mucosal immunoglobulin-A responses and protection

Ulrika Marking; Oscar Bladh; Sebastian Havervall; Julia Svensson; Nina Greilert-Norin; Katherina Aguilera; Martha Kihlgren; Ann Cristin Salomonsson; Maja Månsson; Radiosa Gallini; Cecilia Kriegholm; Philip Bacchus; Sophia Hober; Max Gordon; Kim Blom; Anna Smed-Sörensen; Mikael Åberg; Jonas Klingström; Charlotte Thålin

doi:10.1016/S1473-3099(22)00834-9

7-month duration of SARS-CoV-2 mucosal immunoglobulin-A responses and protection

Ulrika Marking, Oscar Bladh, Sebastian Havervall, Julia Svensson, Nina Greilert-Norin, Katherina Aguilera, Martha Kihlgren, Ann Cristin Salomonsson, Maja Månsson, Radiosa Gallini, Cecilia Kriegholm, Philip Bacchus, Sophia Hober, Max Gordon, Kim Blom, Anna Smed-Sörensen, Mikael Åberg, Jonas Klingström, Charlotte Thålin

Avdelningen för klinisk genetik

Forskningsoutput: Tidskriftsbidrag › Letter › Peer review

Originalspråk	engelska
Sidor (från-till)	150-152
Antal sidor	3
Tidskrift	The Lancet Infectious Diseases
Volym	23
Nummer	2
DOI	https://doi.org/10.1016/S1473-3099(22)00834-9
Status	Published - 2023 feb.

Ämnesklassifikation (UKÄ)

Infektionsmedicin

Tillgång till dokument

10.1016/S1473-3099(22)00834-9

Citera det här

Marking, U., Bladh, O., Havervall, S., Svensson, J., Greilert-Norin, N., Aguilera, K., Kihlgren, M., Salomonsson, A. C., Månsson, M., Gallini, R., Kriegholm, C., Bacchus, P., Hober, S., Gordon, M., Blom, K., Smed-Sörensen, A., Åberg, M., Klingström, J., & Thålin, C. (2023). 7-month duration of SARS-CoV-2 mucosal immunoglobulin-A responses and protection. The Lancet Infectious Diseases, 23(2), 150-152. https://doi.org/10.1016/S1473-3099(22)00834-9

@article{42298b443ecd4ca8b1143fe4ea484d5b,

title = "7-month duration of SARS-CoV-2 mucosal immunoglobulin-A responses and protection",

author = "Ulrika Marking and Oscar Bladh and Sebastian Havervall and Julia Svensson and Nina Greilert-Norin and Katherina Aguilera and Martha Kihlgren and Salomonsson, {Ann Cristin} and Maja M{\aa}nsson and Radiosa Gallini and Cecilia Kriegholm and Philip Bacchus and Sophia Hober and Max Gordon and Kim Blom and Anna Smed-S{\"o}rensen and Mikael {\AA}berg and Jonas Klingstr{\"o}m and Charlotte Th{\aa}lin",

year = "2023",

month = feb,

doi = "10.1016/S1473-3099(22)00834-9",

language = "English",

volume = "23",

pages = "150--152",

journal = "The Lancet. Infectious Diseases",

issn = "1474-4457",

publisher = "Elsevier",

number = "2",

}

Marking, U, Bladh, O, Havervall, S, Svensson, J, Greilert-Norin, N, Aguilera, K, Kihlgren, M, Salomonsson, AC, Månsson, M, Gallini, R, Kriegholm, C, Bacchus, P, Hober, S, Gordon, M, Blom, K, Smed-Sörensen, A, Åberg, M, Klingström, J & Thålin, C 2023, '7-month duration of SARS-CoV-2 mucosal immunoglobulin-A responses and protection', The Lancet Infectious Diseases, vol. 23, nr. 2, s. 150-152. https://doi.org/10.1016/S1473-3099(22)00834-9

TY - JOUR

T1 - 7-month duration of SARS-CoV-2 mucosal immunoglobulin-A responses and protection

AU - Marking, Ulrika

AU - Bladh, Oscar

AU - Havervall, Sebastian

AU - Svensson, Julia

AU - Greilert-Norin, Nina

AU - Aguilera, Katherina

AU - Kihlgren, Martha

AU - Salomonsson, Ann Cristin

AU - Månsson, Maja

AU - Gallini, Radiosa

AU - Kriegholm, Cecilia

AU - Bacchus, Philip

AU - Hober, Sophia

AU - Gordon, Max

AU - Blom, Kim

AU - Smed-Sörensen, Anna

AU - Åberg, Mikael

AU - Klingström, Jonas

AU - Thålin, Charlotte

PY - 2023/2

Y1 - 2023/2

U2 - 10.1016/S1473-3099(22)00834-9

DO - 10.1016/S1473-3099(22)00834-9

M3 - Letter

C2 - 36640796

AN - SCOPUS:85147089268

SN - 1474-4457

VL - 23

SP - 150

EP - 152

JO - The Lancet. Infectious Diseases

JF - The Lancet. Infectious Diseases

IS - 2

ER -